FEATURED/ARCHIVES (04/05/24)
×
Antipsychotic Adherence Patterns and Health Care Utilization and Costs among Patients Discharged After a Schizophrenia-Related Hospitalization · October 2013
Articles
BMC Psychiatry
×
Decision Analysis Model Evaluating the Cost-Effectiveness of Risperidone, Olanzapine and Haloperidol in the Treatment of Schizophrenia (NHS Economic Evaluation Database) · June 2007
Abstracts
University of York>Journal of Evaluation in Clinical Practice
×
Clinical Effectiveness and Cost-Effectiveness of Tailored Intensive Liaison between Primary and Secondary Care to Identify Individuals at Risk of a First Psychotic Illness (The LEGs Study): A Cluster-Randomised Controlled Trial · August 2015
Articles
Lancet Psychiatry
×
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR · July 2020
Articles
Clinical Drug Investigation
×
Adherence to Treatment with Antipsychotic Medication and Health Care Costs among Medicaid Beneficiaries with Schizophrenia · April 2004
Articles
American Journal of Psychiatry
×
Health Care Resource Utilization and Costs Associated with Transitioning to 3-Month Paliperidone Palmitate among US Veterans · August 2018
Articles
Clinical Therapeutics
×
Clinical Outcomes and Costs for People with Complex Psychosis: A Naturalistic Prospective Cohort Study of Mental Health Rehabilitation Service Users in England · April 2016
Articles
BMC Psychiatry
×
Cost-Effectiveness of First- versus Second-Generation Antipsychotic Drugs: Results from a Randomised Controlled Trial in Schizophrenia Responding Poorly to Previous Therapy · July 2007
Articles
British Journal of Psychiatry
×
Does Change in Cognitive Function Predict Change in Costs of Care for People with a Schizophrenia Diagnosis Following Cognitive Remediation Therapy? · March 2014
Articles
Schizophrenia Bulletin
×
Cost-Utility Analysis of Repetitive Transcranial Magnetic Stimulation as Add-On Therapy to Standard Care for the Treatment of Hallucinations in Schizophrenia · March 2022
Articles
European Psychiatry
×
Clinical and Cost Consequences of Metabolic Effects of Lurasidone versus Other Atypical Antipsychotics in Schizophrenia · June 2014
Articles
Open Medicine Journal
×
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate vs. Haloperidol Decanoate in Maintenance Treatment of Schizophrenia · June 2016
Articles
Psychiatric Services
×
The Cost of Inpatient Care of Schizophrenia in the Polish and Ukrainian Academic Centers-Poznan and Lviv · September 2014
Articles
Academic Psychiatry
×
Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs · June 2016
Articles
PLOS ONE
×
Predicting Future High-Cost Schizophrenia Patients Using High-Dimensional Administrative Data · June 2017
Articles
Frontiers in Psychiatry
×
A Cost-Utility Analysis of Amisulpride and Paliperidone in the Treatment of Schizophrenia · September 2019
Articles
Heliyon
×
Randomised Controlled Trial to Improve Health and Reduce Substance Use in Established Psychosis (IMPaCT): Cost-Effectiveness of Integrated Psychosocial Health Promotion · December 2017
Articles
BMC Psychiatry